Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Colgate-Palmolive (CL.N)

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (US$) Price Target (US$) Rating
2021-08-1379.4494.00Buy
2021-10-0475.0689.00Buy
2022-01-1783.4593.00Buy
2022-04-1980.6190.00Buy
2022-05-0177.0586.00Buy
2022-07-2277.4788.00Buy
2022-08-0181.1090.00Buy
2022-10-1371.0180.00Buy
2022-10-3173.8485.00Buy
2023-01-2971.5984.00Buy
2023-03-2974.4786.00Buy
2023-04-3079.8091.00Buy
2023-06-2875.9190.00Buy
2023-07-3176.2693.00Buy
2023-10-1168.8785.00Buy
2024-01-1580.9193.00Buy
2024-01-2882.8395.00Buy
2024-04-0987.65103.00Buy
2024-04-2990.49105.00Buy
2024-07-1298.07114.00Buy
2024-07-29100.88119.00Buy
2024-09-03107.78122.00Buy
2024-10-2895.74112.00Buy

Disclosures

  • UBS Securities LLC makes a market in the securities and/or ADRs of this company.
  • UBS holds a long or short position of 0.5% or more of the listed shares of this company.
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day.